Trinity Biotech plc (TRIB)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 14.37M |
| Enterprise value | 75.12M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.20 |
| Price/book (mrq) | 5.11 |
| Enterprise value/revenue | 1.05 |
| Enterprise value/EBITDA | -2.85 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.23 |
| 52-week change 3 | -66.43% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 5.6000 |
| 52-week low 3 | 1.7900 |
| 50-day moving average 3 | 2.1954 |
| 200-day moving average 3 | 2.8684 |
Share statistics
| Avg vol (3-month) 3 | 98.56k |
| Avg vol (10-day) 3 | 24.5k |
| Shares outstanding 5 | 7.64M |
| Implied shares outstanding 6 | 7.64M |
| Float 8 | 69.35M |
| % held by insiders 1 | 29.31% |
| % held by institutions 1 | 39.27% |
| Shares short (28 Mar 2024) 4 | 1.16k |
| Short ratio (28 Mar 2024) 4 | 0.07 |
| Short % of float (28 Mar 2024) 4 | 0.02% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.02% |
| Shares short (prior month 29 Feb 2024) 4 | 15.3k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 1.19 |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 01 Jul 2015 |
| Ex-dividend date 4 | 05 Jun 2015 |
| Last split factor 2 | 1:5 |
| Last split date 3 | 23 Feb 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -42.26% |
| Operating margin (ttm) | -25.98% |
Management effectiveness
| Return on assets (ttm) | -13.15% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 56.83M |
| Revenue per share (ttm) | 7.42 |
| Quarterly revenue growth (yoy) | -25.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -14.16M |
| Net income avi to common (ttm) | -36.87M |
| Diluted EPS (ttm) | -4.9600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.69M |
| Total cash per share (mrq) | 0.02 |
| Total debt (mrq) | 54.86M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.60 |
| Book value per share (mrq) | -3.12 |
Cash flow statement
| Operating cash flow (ttm) | -11.56M |
| Levered free cash flow (ttm) | -11.02M |
© 2024 Yahoo. All rights reserved.